Skip to main content
CDT
NASDAQ Life Sciences

CDT Equity Secures $1.46M Loan, Repays $6.3M Debt, and Restructures Balance Sheet

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$0.718
Mkt Cap
$3.487M
52W Low
$0.671
52W High
$610
52W Position info
7.1% above low
Off High info
100% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

CDT is trading near its 52-week low of $0.671 (7.1% above the low) on light trading volume (0.1× avg).

Summary

CDT Equity Inc. secured a new $1.46 million convertible loan, enabling the repayment of over $6.3 million in legacy debt for a net reduction of $4.83 million, significantly restructuring its balance sheet and addressing going concern issues.


Key Events · Financing and Capital Events · CDT

  • Major Debt Restructuring

    The company secured a new $1.46 million senior secured convertible promissory note from J.J. Astor & Co. This enabled the repayment of a $5.74 million convertible loan note with A.G.P. and a $0.56 million promissory note with Ascent Partners, resulting in a net debt reduction of approximately $4.83 million.

  • New Convertible Note and Warrants Issued

    The $1.97 million principal amount note (from which $1.46 million was received) is convertible by the lender at 90% of the lowest 10-day VWAP or Nasdaq floor price after six months. In case of default, the outstanding amount increases by 20% and accrues 19% interest, with a conversion price of 70% of the lowest 20-day VWAP or floor price. Warrants to purchase 912,500 shares at an exercise price of $0.72 per share were also issued, exercisable upon stockholder approval.

  • Nasdaq Compliance Covenants

    The loan agreement includes covenants requiring the company to cure its Nasdaq deficiency for failing to file its Q1 2026 10-Q within 30 days and to maintain its Nasdaq listing, directly addressing recent compliance issues.

  • ATM Proceeds Allocated to Debt Repayment

    80% of the net proceeds from the company's existing At-The-Market (ATM) equity offering program will be used to pay down the weekly installments of the new note, and 50% thereafter until the note is fully satisfied.


Analysis · CDT · Life Sciences

CDT Equity Inc., a company previously flagged with a 'going concern' warning, has significantly restructured its balance sheet by securing a new $1.46 million senior secured convertible promissory note for working capital. Crucially, this new financing facilitated the repayment of over $6.3 million in legacy debt, resulting in a net debt reduction of approximately $4.83 million. This substantial debt reduction, representing over 138% of the company's current market capitalization, is a critical step towards addressing its financial distress and extending its operational runway. The agreement also includes covenants to cure a Nasdaq deficiency related to overdue filings, directly addressing compliance risks. While the new note and associated warrants introduce potential future dilution through convertible shares and warrants, the immediate benefit of debt reduction and securing vital capital for a distressed company is a strong positive for its continued operations.

At the time of this filing, CDT was trading at $0.72 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.5M. The 52-week trading range was $0.67 to $610.00. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CDT - Latest Insights

CDT
Jul 16, 2026, 8:05 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.322
Real-time Price: $3.06 info
Change: Reverse Stock Split info
Market Cap: $1.931M info
CDT
Jul 16, 2026, 8:04 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.2815
Real-time Price: $3.06 info
Change: Reverse Stock Split info
Market Cap: $1.931M info
CDT
Jul 15, 2026, 4:51 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.3503
Real-time Price: $3.06 info
Change: Reverse Stock Split info
Market Cap: $1.931M info
CDT
Jul 15, 2026, 4:46 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.3503
Real-time Price: $3.06 info
Change: Reverse Stock Split info
Market Cap: $1.931M info
CDT
Jul 07, 2026, 5:20 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.425
Real-time Price: $3.06 info
Change: Reverse Stock Split info
Market Cap: $1.931M info